StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report issued on Monday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of NYSE CO opened at $1.25 on Monday. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The stock has a market cap of $151.94 million, a PE ratio of 1.95 and a beta of 0.16. The stock has a fifty day moving average of $1.56 and a 200-day moving average of $1.38.
About Global Cord Blood
Further Reading
- Five stocks we like better than Global Cord Blood
- Options Trading – Understanding Strike Price
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What Are Some of the Best Large-Cap Stocks to Buy?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Dividend Payout Ratio Calculator
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.